| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Monday’s Close |
|---|---|---|---|---|---|
| AGN | Allergan plc. | $184.29 | $62.56B | N/A |
Sarepta Appoints Ex-Allergan Executive as CEO and President
http://www.zacks.com/stock/news/266054/sarepta-appoints-ex-allergan-executive-as-ceo-and-president?cid=CS-ZC-FT-266054
Jun 29, 2017 - Sarepta Therapeutics, Inc. (SRPT) announced the appointment of Douglas S. Ingram as the new chief executive officer (CEO).
0
Saint Agnes continues to scout for tenants at Gibbons Commons development
http://feeds.bizjournals.com/~r/industry_20/~3/q2pAk5IHwhQ/saint-agnes-continues-to-scout-for-tenants-at.html
Jun 21, 2017 - 
The project on 32 acres at the former Cardinal Gibbons High School site.
0
The project on 32 acres at the former Cardinal Gibbons High School site.
0
Could Legalized Marijuana Be Making Big Pharma Nervous?
https://www.fool.com/investing/2017/06/18/could-legalized-marijuana-be-making-big-pharma-ner.aspx?source=iedfolrf0000001
Jun 18, 2017 - A new report says that drugmakers could lose billions of dollars per year if marijuana is legalized throughout the U.S. Should Pfizer, Allergan, and others be nervous?
0
AGN: Cantor Fitzgerald starts at Neutral
http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20170616083137
Jun 16, 2017 - Cantor Fitzgerald issues rating change for AGN
0
Pittsburgh hosting AGN International accounting conference
http://feeds.bizjournals.com/~r/industry_19/~3/mXbTTWv0HpU/pittsburgh-hosting-accounting-conference.html
Jun 15, 2017 - 
More than 200 accountants will be in Pittsburgh starting Tuesday as a worldwide association of independent accounting and advisory firms brings its regional meeting downtown for the first time.
AGN International is holding its 2017 North American Regional Meeting June 20-22 at the Omni William Penn Hotel in downtown Pittsburgh. AGN originally stood for Accounting Global Network. The local member of AGN is Sisterson & Co. LLP, which joined in 2002 and championed bringing the meeting here.
“I’ve…
0
More than 200 accountants will be in Pittsburgh starting Tuesday as a worldwide association of independent accounting and advisory firms brings its regional meeting downtown for the first time.
AGN International is holding its 2017 North American Regional Meeting June 20-22 at the Omni William Penn Hotel in downtown Pittsburgh. AGN originally stood for Accounting Global Network. The local member of AGN is Sisterson & Co. LLP, which joined in 2002 and championed bringing the meeting here.
“I’ve…
0
5 Things Allergan's Management Just Said That You Need to Know
https://www.fool.com/investing/2017/06/15/5-things-allergans-management-just-said-that-you-n.aspx?source=iedfolrf0000001
Jun 15, 2017 - Allergan executives hint at what's in store for the drugmaker at the Goldman Sachs healthcare conference.
0
Agnes Gund Sells a Lichtenstein to Start Criminal Justice Fund
https://www.nytimes.com/2017/06/11/arts/design/agnes-gund-sells-a-lichtenstein-to-start-criminal-justice-fund.html?partner=rss&emc=rss
Jun 11, 2017 - Ms. Gund has asked other collectors to help champion her social cause, which she has seeded with $100 million of the proceeds from the sale.
129K
AGN: Mizuho reits Buy
http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20170609055847
Jun 09, 2017 - Mizuho issues rating change for AGN
0
Is Ironwood's Growth About to Slow?
https://www.fool.com/investing/general/2017/06/05/is-ironwoods-growth-about-to-slow.aspx?source=iedfolrf0000001
Jun 05, 2017 - New competition could slow prescription growth for Linzess and take some of the luster off this small-cap biotech stock.
4
Aerie's Ophthalmic Candidate Positive in Registration Trial
http://www.zacks.com/stock/news/261948/aeries-ophthalmic-candidate-positive-in-registration-trial?cid=CS-ZC-FT-261948
May 25, 2017 - Aerie Pharmaceuticals, Inc. (AERI) announced positive primary efficacy results of the 90-day phase III registration trial -- Mercury 2 -- for its pipeline candidate Roclatan.
0